Status:
COMPLETED
The Impact of the Biopsy of 1-2 Cells in a PGD Program for Anueploidy Screening
Lead Sponsor:
Instituto Valenciano de Infertilidad, IVI VALENCIA
Conditions:
Healthy
Eligibility:
All Genders
25-45 years
Phase:
NA
Brief Summary
The aim of this study is to evaluate the impact of the biopsy of one or two cells in a preimplantatation genetic diagnosis program (PGD) for the screening of aneuploidies. This prospective and randomi...
Eligibility Criteria
Inclusion
- Patients undergoing PGD for aneuploidy screening with their own oocytes and for chromosomes 13, 16, 18, 21, 22, X \& Y
Exclusion
- Patients undergoing PGD for monogenic diseases (PCR)
- Patients undergoing PGD for structural chromosomal abnormalities
- Ovum donation cycles
- Cryopreserved oocyte/embryos
Key Trial Info
Start Date :
November 1 2007
Trial Type :
INTERVENTIONAL
End Date :
December 1 2008
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00454311
Start Date
November 1 2007
End Date
December 1 2008
Last Update
March 4 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Instituto Valenciano de la Infertilidad
Valencia, Spain, 46015